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Abstract
The yeast Mediator complex can be divided into three modules, designated Head, Middle and Tail. Tail comprises the Med2,
Med3, Med5, Med15 and Med16 protein subunits, which are all encoded by genes that are individually non-essential for
viability. In cells lacking Med16, Tail is displaced from Head and Middle. However, inactivation of MED5/MED15 and MED15/
MED16 are synthetically lethal, indicating that Tail performs essential functions as a separate complex even when it is not
bound to Middle and Head. We have used the N-Degron method to create temperature-sensitive (ts) mutants in the
Mediator tail subunits Med5, Med15 and Med16 to study the immediate effects on global gene expression when each
subunit is individually inactivated, and when Med5/15 or Med15/16 are inactivated together. We identify 25 genes in each
double mutant that show a significant change in expression when compared to the corresponding single mutants and to
the wild type strain. Importantly, 13 of the 25 identified genes are common for both double mutants. We also find that all
strains in which MED15 is inactivated show down-regulation of genes that have been identified as targets for the Ace2
transcriptional activator protein, which is important for progression through the G1 phase of the cell cycle. Supporting this
observation, we demonstrate that loss of Med15 leads to a G1 arrest phenotype. Collectively, these findings provide insight
into the function of the Mediator Tail module.
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Introduction
Regulation of transcription in eukaryotes by RNA polymerase II
(Pol II) is controlled by factors that affect chromatin packing,
chromatin structure and by regulatory proteins (activators and
repressors) that bind to specific DNA sequences in promoters. In
the latter process, the Mediator co-activator complex is required to
convey signals from the promoter-bound regulatory proteins to the
Pol II transcription machinery [1,2]. Mediator is an essential and
evolutionarily conserved protein complex that is required for
transcription of almost all protein encoding genes in eukaryotic
cells. It was first identified in budding yeast, and it has since been
identified in higher eukaryotes such as S. pombe, C. elegans, human
and A. thaliana [3–6]. These studies showed that the function and
overall structure of Mediator is evolutionarily conserved. Mediator
in S.cerevisiae comprises 25 different subunits and a combination of
genetics, biochemistry and structure biology has revealed that it is
composed of three modules; Head, Middle, and Tail [7–11]. In
addition, Mediator can also associate with a separate kinase
module comprising Cdk8, cyclin C, Med12 and Med13. The head
module interacts directly with Pol II and stimulates basal,
unregulated transcription [1,2,12–14]. Tail is suggested to make
direct interactions with promoter-bound transcriptional regulators
and is located most distal from Pol II, where it is bridged to the
Middle module via the Med14 subunit [7,15]. The Cdk8 module
is more loosely associated and reversibly associates with Mediator
to regulate the Mediator–Pol II interaction [7–11,16] to control
transcription initiation and reinitiation.
Several lines of evidence indicate that Tail is important for
activation of transcription and numerous reports have identified
tail subunits as targets for different transcriptional regulatory
proteins (see ref [17] for a review). However, there are also reports
on direct interactions between transcriptional regulators and
subunits of the Head and Middle modules [18–20]. Three-
dimensional reconstruction from electron micrographs of single
Mediator particles isolated from med16 (sin4) mutants shows that
the entire tail domain is absent from the purified complex [21].
Since med16 cells are viable, it was initially difficult to understand
how Tail can play such a fundamental role in the transcription
activation process given that all tail module subunits are encoded
by non-essential genes. Interestingly, it appears that Tail does not
have to be physically connected to Head and Middle in order to
function properly. In fact, in the med16 mutant, Tail subunits are
present in a distinct protein complex that is separate from Head
and Middle [22]. The free tail complex in med16 comprises Med2,
Med3 (Hrs1), and Med15 (Gal11) and can be functionally
recruited to the ARG1 promoter by interaction with the
transcriptional activator protein Gcn4. Opposite to the situation
PLOS ONE | www.plosone.org 1 August 2013 | Volume 8 | Issue 8 | e73137
in wild type cells, the Head and Middle modules were not
recruited to the ARG1 promoter in med16 cells upon activation.
Recruitment of Tail alone was sufficient to recruit TBP and Pol II
to the ARG1 promoter and resulted in induction of ARG1 mRNA
expression to the same levels as in wild type cells. In contrast, the
ARG1 mRNA levels were markedly de-repressed under non-
inducing conditions in the med16 strain compared to wild type
cells. Similar results were obtained in another study describing the
isolation of a ‘‘core Mediator’’-fraction that contained most of the
head and middle module subunits, but lacked Tail [23]. This core
Mediator complex could activate transcription in vitro, but not to
the same extent as complete Mediator. In addition, core Mediator
combined with complete Mediator showed a lower degree of
activation than the complete Mediator alone. Both of these studies
suggest that Tail by itself is mainly involved in transcriptional
activation, while Middle and Head together predominantly
function in transcriptional repression. Further supporting this
concept, we have previously reported that the Med2 subunit of the
Tail complex is phosphorylated by the Cdk8 kinase on serine 208
and that a mutation of serine 208 in Med2 to an alanine resulted
in a dramatic down regulation of expression of genes encoded on
the 2 mM plasmid and an upregulation of a limited set of genes
[24]. In line with these results, epistasis and expression profile
analysis show that MED2 and also MED18 act downstream of
CDK8 [25].
In support of an essential role for the Tail complex, it has been
shown that double deletions of either MED5 and MED15 or
MED15 and MED16 are synthetically lethal [26,27]. However, the
cause of the synthetic lethality has not been studied in detail. Here
we have used the N-Degron method to create temperature-
sensitive (ts) mutants in the Mediator tail subunits Med5, Med15
and Med16. We show that conditional and concomitant inacti-
vation of MED5 and MED15 or MED15 and MED16 results in
altered expression of a limited set of genes that partly overlap.
Interestingly, several of these genes are involved in meiosis and
sporulation. In support of this observation, all strains where
MED15 was inactivated showed cell cycle defects and repression of
target genes for the Ace2 activator protein.
Materials and Methods
Yeast strains
YKL200 (obtained from Euroscarf) was used as wild type
control for the Degron strains. Single-Degron strains (med5, med15
and med16) and double-Degron strains (med5/med15 and med15/
med16) were created.
The Degron system
The degron system was used to deplete a specific protein from S.
Cerevisiae cells and to examine the immediate effects of the
depletion. In short we inserted a degron cassette in the
chromosomal locus of the MED5, MED15 and MED16 genes as
described below. The native promoters were replaced by the
CUP1 promoter, and a so-called ‘‘heat-inducible degron’’ was
added to the N-terminus of each protein. The CUP1 promoter
was activated at the permissive growth conditions (YPD(/R)Cu-
medium, containing CuSO4 and glucose (or raffinose), growing at
24uC) due to the presence of copper in the medium and the
degron-tag is inactivated due to the low temperature. At the
restrictive growth conditions (YPG-medium, lacking CuSO4 and
glucose (or raffinose), containing galactose, growing at 37uC)
expression of each protein was repressed due to lack of copper and
degraded by activation of the degron-tag due to the increased
temperature. For more details on the degron system see [28].
Change of selectable marker in pKL187 (Degron strains)
The KanMX gene was replaced with the NatMX (nourseothricin
resistance) from the pAG25 plasmid [29]. pAG25 and pKL187
were digested with NotI (Fermentas) for 12 hours at 37u C over
night, and the resulting linearized vector pKLK187 and the
natMX fragment was purified (QIAquick Gel Extraction Kit,
Qiagen). pKL187 was treated with Shrimp alkaline phosphatase
and natMX was ligated (T4 DNA ligase, Invitrogen) into pKL187.
Creation of Degron strains
Amplification of the Degron cassette and transformation was
performed as described in [28]. When clones were selected with
nourseothricin 100 mg/ml clonNAT (Hans-Kno¨ll Institute fu¨r
Naturstoff-Forshung, Jena, Germany) was used. The following



















Handling of the Degron strains and verification of integration
was carried out as described [28]. Sequences for primers for
verification are available upon request. All PCR-reactions were
carried out using PlatinumH Pfx DNA polymerase (Invitrogen).
Single-Degron strains were created by selection for clonNAT for
med5 and G418 for med15 and med16. Double-Degron strains were
obtained with a second round of transformation with an amplified
Degron cassette with the other selectable marker and selection for
both clonNAT and G418.
Plate serial dilution of Degron strains
All growth conditions are outlined in [28]. Briefly, colonies of
each strain were dissolved in PBS and diluted to approximately
3.36106 cells/ml. From this dilution three more 10-fold dilutions
were made for each strain. 15 ml of each dilution was dropped on
to YPDCu-agar (2% peptone, 1% Yeast extract, 2% glucose,
0.1 M CuSO4, 2% agar) plates and YPG-agar (2% peptone, 1%
Yeast extract, 2% galactose, 2% agar) plates. The plates where
incubated for 2 days at 24uC (YPDCu) and 37uC (YPG).
Growth curves of Degron strains
All growth conditions are outlined in [28]. Briefly, colonies from
each strain were dissolved in 100 ml of YPRCu medium (2%
peptone, 1% Yeast extract, 2% raffinose, 0.1 M CuSO4) and
grown over night on a shaker at 24uC. The cell density was
measured and the cultures where diluted with fresh YPRCu
medium to 56106 cells/ml. Growth was continued until the cell
density reached 107 cells/ml. The cells where then pelleted and
dissolved in YPG medium (2% peptone, 1% Yeast extract, 2%
galactose). The cells where incubated at 24uC for 35 minutes to
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induce the expression of the Ubr1 protein, and then pelleted and
dissolved in pre-warmed 37uC YPG medium. The cells where then
incubated at 37uC on a shaker and harvested at the indicated time
points to examine the growth effects of depleting the proteins.
Western blotting
Proteins were extracted as described in [30] and run on
NuPAGE 3–8% Tris-Acetate gels (Invitrogen). The gels were
blotted to HybondTM-P membranes (Amersham), blocked in 2%
milk in TBST and subjected to primary antibody. Horseradish
peroxidase linked secondary antibody was added for detection of
primary antibody. The a-Med5, a-Med15 and a-Med16 antibod-
ies are polyclonal antibodies produced in rabbit using synthesized
peptides. a-Med16 has been affinity purified against its peptide.
The a-cmyc antibody used is mouse monoclonal antibody (clone
9E10).
Microarray analysis of Degron Strains
All strains were grown in YPRCu at 24uC to approximately
16107 cells/ml. The media was switched to YPGalactose and
growth was continued at 24uC for 35 minutes. The cells were
transferred to pre-warmed YPGalactose (37uC) and growth was
continued at 37uC for 45 minutes before harvesting. 2 ml of the
cultures was used for RNA extraction (RNeasy Mini, Qiagen). The
cells were lysed in RLT buffer by bead beating (7630 seconds,
with chilling on ice for one minute before each round of bead
beating). On-column DNase treatment was performed according
to the manufacturer. RNA was quality controlled, reverse
Figure 1. Confirmation of expression and specific, induced
degradation of theMED5,MED15 andMED16Degron constructs.
(A) Crude protein extracts isolated from the wild type strain and each of
the med5, med15, and med16 Degron strains, grown at the permissive
conditions (24uC/YPD/0.1 mM CuSO4), were separated on 10% SDS-
PAGE, transferred to PVDF membranes and blotted with a-Med5, a-
Med15 and a-Med16 antibodies, respectively. (B) Crude protein extracts
were isolated from the wild type strain and each of the med5, med15
and med16 Degron strains at the permissive conditions (uninduced, u.i.)
and 45 minutes after switching to the non-permissive growth
conditions. The extracts were separated on 10% SDS-PAGE, transferred
to PVDF membranes and blotted with anti c-myc antibodies (specific for
the Degron-tag). (C) Specific degradation of Degron-tagged MED5.
Crude protein extracts were isolated from the wild type strain, the med5
Degron strain, and the med15 Degron strain 45 minutes after switching
to the restrictive growth conditions. Proteins were separated on 10%
SDS-PAGE, transferred to PVDF-membranes and blotted with a-Med5
antibodies.
doi:10.1371/journal.pone.0073137.g001
Figure 2. Double deletions of yeast MED5/MED15 and MED15/
MED16 are synthetically lethal. (A) The strains indicated to the left
were plated as 10-fold serial dilutions, 5 ml spots at permissive
conditions (24uC, Cu++, glucose) and restrictive conditions (37uC, no
Cu++, galactose) respectively. (B) The strains indicated to the right were
grown in liquid media, at restrictive conditions, for 24 hours. OD600 was
measured at the indicated time points. OD600 at 0 hours was set to 1
and the other values where normalized against time= 0 min. The
graphs represent the mean of two separate experiments. The graphs
represent the mean of two separate experiments, and the error bars
represent the standard deviation.
doi:10.1371/journal.pone.0073137.g002
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Table 1. Genes whose expression is changed 1.5-fold or more in the med5/med15 double Degron strain compared to either of the
wild type, med5 or med 15 and in the med15/med16 double Degron strains compared to either of the wild type, med15 or med 16







YOL155C HPF1 Q Q Haze-protective mannoprotein
YGL158W RCK1 Q Q Protein kinase involved in the response to oxidative stress and in inhibition of meiosis
YHR143W DSE2 Q Q Daughter cell-specific secreted protein with similarity to glucanases degrades cell wall
from the daughter side causing daughter to separate from mother
YHR092C HXT4 Q Q High-affinity glucose transporter of the major facilitator superfamily, expression is
induced by low levels of glucose and repressed by high levels of glucose
YIL169C NA Q Q Putative protein of unknown function
YGL028C SCW11 Q Cell wall protein with similarity to glucanases; may play a role in conjugation during mating
YER124C DSE1 Q Daughter cell-specific protein, may regulate cross-talk between the mating and filamentation pathways
YPL067C NA Q Putative protein of unknown function
YOR178C GAC1 Q Regulatory subunit for Glc7p type-1 protein phosphatase (PP1)
YLR377C FBP1 Q Fructose-1,6-bisphosphatase, key regulatory enzyme in the gluconeogenesis pathway
YPL036W PMA2 Q Plasma membrane H+–ATPase
YAR035W YAT1 Q Outer mitochondrial carnitine acetyltransferase
Upregulated
YGL033W HOP2 q q Meiosis-specific protein that localizes to chromosomes, preventing synapsis between
non-homologous chromosomes and ensuring synapsis between homologs; complexes
with Mnd1p to promote homolog pairing and meiotic double-strand break repair
YLR341W SPO77 q q Meiosis-specific protein of unknown function required for spore wall formation during sporulation
YOL132W GAS4 q q 1,3-beta-glucanosyltransferase, involved in spore wall assembly, localizes to the cell wall
YBR040W FIG1 q q Integral membrane protein required for efficient mating
YGR273C IBI1 q q Putative protein of unknown function, expression downregulated by treatment with 8-methoxypsoralen
plus UVA irradiation
YFL012W NA q q Putative protein of unknown function, transcribed during sporulation
YDR042C NA q q Putative protein of unknown function
YGL138C NA q q Putative protein of unknown function
YOR339C UBC11 q Ubiquitin-conjugating enzyme
YDR446W ECM11 q Protein apparently involved in meiosis, may be involved in maintaining chromatin structure
YPL130W SPO19 q Meiosis-specific prospore protein; required to produce bending force necessary
for proper assembly of the prospore membrane during sporulation
YOR237W HES1 q Protein implicated in the regulation of ergosterol biosynthesis
YOR242C SSP2 q Sporulation specific protein that localizes to the spore wall, required for sporulation
at a point after meiosis II and during spore wall formation
YDR218C SPR28 q Sporulation-specific homolog of the yeast CDC3/10/11/12 family of bud neck microfilament
genes; meiotic septin expressed at high levels during meiotic divisions and ascospore formation
YDL114W NA q Putative protein of unknown function
YOL014W NA q Putative protein of unknown function
YPL033C SRL4 q Putative protein of unknown function, involved in regulation of dNTP production
YGR177C ATF2 q Alcohol acetyltransferase
YNL111C CYB5 q Cytochrome b5, involved in the sterol and lipid biosynthesis pathways
YHR185C PFS1 q Sporulation protein required for prospore membrane formation at selected spindle poles
YML047C PRM6 q Pheromone-regulated protein
YJR047C ANB1 q Translation elongation factor eIF-5A, previously thought to function in translation initiation;
similar to and functionally redundant with Hyp2p; expressed under anaerobic conditions
YKL165C MCD4 q Protein involved in glycosylphosphatidylinositol (GPI) anchor synthesis
YNL130C-A DGR1 q Putative protein of unknown function; dgr1 null mutant is resistant to 2-deoxy-D-glucose
YOR381W-A NA q Putative protein of unknown function
doi:10.1371/journal.pone.0073137.t001
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transcribed and labeled before hybridized to AffymetrixsH Yeast
Genome 2.0 Arrays. All strains were grown independently twice
and two independent data sets were obtained for each strain. The
resultant CEL files were normalized using robust multi-array
average (RMA) background correction. Genes with an average
fold-change . 1.5 were considered differentially expressed. The
microarray dataset has been deposited in Gene Expression
Omnibus (GEO) under accession number GSE47712.
RT-PCR
RNA was extracted as described for microarray analysis. RNA
concentrations were measured using a NanoDrop, ND-1000
spectrophotometer. 1 mg of RNA was reverse transcribed using an
iScript cDNA Synthesis Kit (BioRad). qPCR was carried out using
IQTM Supermix (BioRad). Equal amounts of cDNA and 500 nM
primers were used in each reaction in a total volume of 25 ml. PCR
reactions and detection was carried out on iCycler IQ PCR thermal
cycler (BioRad). All samples were analyzed in triplicates, and the
measured concentration of RNA was normalized to the levels of
ACT1 mRNA. Sequences for primers are available upon request.
Flow cytometry
Determination of DNA content in the different yeast mutants at
different time points after switching from permissive to restrictive
conditions was performed exactly as described [31].
Results
Construction of Heat-inducible N-Degron Mutants for
med5, med15 and med16
We adopted the N-Degron system to obtain copper-dependent
expression as well as galactose- and temperature-dependent
degradation of the Med5, Med15 and Med16 Mediator subunits,
either individually or pairwise [28]. All Degron constructs were
expressed from their normal chromosomal location under the
control of their respective endogenous promoters. In order to
study the expression of the Degron-tagged proteins, we prepared
whole-cell protein extracts from wild type cells and from each
single Degron strain. The extracts were analyzed by Western
blotting using antibodies specific for each protein (Figure 1A). We
found that the Degron-tagged Med5, Med15 and Med16 were all
expressed at levels similar to the levels of each protein in the
parental wild type strain. When comparing the levels of each
Degron-tagged protein, before and after heat-induction, we found
that each Degron-tagged protein was efficiently depleted from the
extracts already at 45 minutes after heat-induction (Figure 1B).
Finally, we also tested that the heat-degradation of Med5 was
specific to the strain expressing the Degron-tagged version. We
found that untagged Med5 is stable in both the wild type strain
and in the strain that expresses a Degron-tagged version of
Med15, but degraded in the strain that expresses the Degron-
tagged Med5 (Figure 1C). Thus, we conclude that the mutant
strains encoding Degron-tagged versions of Med5, Med15 and
Med16 function properly.
Synthetic lethality in strains lacking both Med5 and
Med15 or both Med15 and Med16
We and others have previously reported that single disruptions
of MED5, MED15 or MED16 are viable, in contrast to double
deletions of MED5 and MED15 or MED15 and MED16, which all
cause synthetic lethality [26,27]. However, because the cells
carrying the double deletions do not grow it has not previously
been possible to study the cause of lethality. In order to test if we
could reproduce the synthetic lethality in a controlled, heat-
inducible way using the N-Degron system, we grew wild type cells,
strains expressing individual Med5, Med15 or Med16 N-Degron
constructs and strains that express N-Degron-tagged versions of
both Med5/Med15 and Med15/Med16, respectively. The cells
were initially grown in YPD at 24uC (permissive conditions), then
transferred either to YPG-plates (Figure 2A) or liquid YPG-media
(Figure 2B) and moved to 37uC (restrictive conditions). When the
cells were grown on plates, degradation of Med5 alone had little or
no effect on growth, while single degradation of Med16 showed a
mild growth defect, and single degradation of Med15 showed a
more pronounced effect on growth. This limited growth effect for
a med15 mutant has been reported previously [27]. In contrast, we
found that both the med5/med15 and the med15/med16 double
Degron strains were unable to grow on plates at the restrictive
conditions (Figure 2A). These results indicate that the N-Degron
system can be used to reproduce the effects of ts mutants in the tail
module that have been created using conventional methods.
Similar results were obtained in liquid media (Figure 2B).
Analyses of global gene expression in the single and
double Degron strains at the restrictive conditions
In order to identify genes that are differentially regulated and
therefore could contribute to the synthetic lethality of cells lacking
both Med5/Med15 or Med15/Med16, we used Affymetrix
microarrays to compare global gene expression in wild type cells
Figure 3. Transcription profile analysis using AffymetrixsYeast
Genome 2.0 Array. 25 genes were differently regulated in both of the
double-Degron strains (med5/med15 (A) and med15/med16 (B)), 45
minutes after induction of degradation, compared to the single Degron
(med5, med15 and med16) and wild type (Wt) strains, as shown in the
Venn diagrams (FDR,0.05 and FC.abs(log2(1.5)).
doi:10.1371/journal.pone.0073137.g003
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and the different Degron strains. We isolated RNA from each
strain 45 minutes after changing from the permissive to the
restrictive growth conditions in order to minimize possible
secondary effects on gene expression that are not directly related
to the Degron construct(s). This time point was chosen based on
the experiments shown in Figure 1B, where the levels of each
Degron-tagged protein was undetectable at 45 minutes after
switching to the restrictive growth conditions. The results from
these experiments including all possible combinations of compar-
isons of expression between wild type cells, single Degron mutants
and double Degron mutants are presented in Tables 1, and S1.
Genes that were differentially expressed in the med5/med15 strain
compared to any individual control strain (WT, med5, and med15
respectively) are depicted as a Venn diagram in Figure 3A.
Interestingly, the microarray results identified a set of only 25
genes that were uniquely differentially expressed in the med5/
med15 double Degron strain, i.e. genes that were differentially
expressed when compared to the wild type, single med5 and single
med15 Degron strains (Figure 3A; Table 1). Considering that the
med15 Degron strain shows the most severe growth defects of all
the single Degron mutant strains, it is interesting to note that only
33 genes (25+5+1+2) were uniquely expressed in the med5/med15
double Degron strain compared to the med15 single Degron strain.
In contrast, 481 genes (25+2+119+335) are differentially expressed
when comparing the med5/med15 double Degron strain with the
med5 single Degron strain and 655 (335+290+25+5) genes are
differently expressed when comparing the med5/med15 double
Degron strain with the wild type strain. These results provide an
explanation why the single med15 Degron strain shows a more
profound growth defect than the single med5 strain.
Similarly, we found that the med15/med16 double Degron strain
showed differential expression of a limited set of 25 genes at the
restrictive conditions compared to the wild type, the single med15
Degron and the single med16 Degron strains (Figure 3B; Table
1). Importantly, of the 25 genes that are uniquely expressed in
each of the double Degron strains, 13 are common to both (Table
1). None of these 13 genes are individually essential for viability,
which strongly suggests that two or more of these genes encode
proteins that together perform essential functions in cells. We
therefore decided to look in more detail at the genes affected in
both the double Degron strains.
The double Degron strains show an abnormal up
regulation of meiosis and sporulation specific genes
Eight genes were specifically down regulated in the med5/med15
double Degron strains compared to the control strains (Table 1).
Similarly, nine genes were specifically down regulated in the
med15/med16 double Degron strains compared to the control
strains (Table 1). Of these, five genes were common for both
double deletion strains (Table 1). Seventeen and sixteen genes,
respectively, were up regulated in the med5/med15 and med15/
med16 double Degron strain compared to the control strains with 8
in common (Table 1). When studying these genes in detail we
found that as many as 9 of them have been shown to be meiosis
specific or involved in sporulation (Table S2). This is interesting
since the strains used in this study are haploid, and therefore do
not go through either meiosis or sporulation. Moreover, we noted
Table 2. Changes in expression levels of genes that are identified as target genes for the transcription factor Ace2 in the med5/
med15, med15/med16 and med15 Degron strains relative to wild type cells.







YAL040C CLN3 G1 cyclin involved in cell cycle progression; activates Cdc28p
kinase to promote the G1 to S phase transition; plays a role in
regulating transcription of the other G1 cyclins, CLN1 and CLN2;
regulated by phosphorylation and proteolysis
1.8 2.0 1.6
YNL327W EGT2 Glycosylphosphatidylinositol (GPI)-anchored cell wall endoglucanase
required for proper cell separation after cytokinesis, expression is
activated by Swi5p and tightly regulated in a cell cycle-dependent manner
1.6 1.8 1.4
YLR286C CTS1 Endochitinase, required for cell separation after mitosis;
transcriptional activation during the G1 phase of the cell
cycle is mediated by transcription factor Ace2p
1.7 1.9 1.4
YLR300W EXG1 Major exo-1,3-beta-glucanase of the cell wall, involved in cell wall
beta-glucan assembly; exists as three differentially glycosylated isoenzymes
1.8 2.2 1.8
YBR157C ICS2 Protein of unknown function 2.0 2.5 2.2
YGR234W YHB1 Nitric oxide oxidoreductase, flavohemoglobin involved in nitric oxide
detoxification; plays a role in the oxidative and nitrosative stress responses
2.1 2.5 2.3
YBR158W AMN1 Protein required for daughter cell separation, multiple mitotic checkpoints,
and chromosome stability; contains 12 degenerate leucine-rich repeat
motifs; expression is induced by the Mitotic Exit Network (MEN)
2.2 2.1 2.0
YJL078C PRY3 Protein of unknown function 2.0 2.2 1.9
YGL028C SCW11 Cell wall protein with similarity to glucanases; may play a role in
conjugation during mating based on its regulation by Ste12p
3.8 3.6 2.4
YER124C DSE1 Daughter cell-specific protein, deletion affects cell separation after
division and sensitivity to drugs targeted against the cell wall
2.2 2.1 1.4
YJL157C FAR1 Cyclin-dependent kinase inhibitor that mediates cell cycle
arrest in response to pheromone
doi:10.1371/journal.pone.0073137.t002
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that one of the genes found to be down regulated in both Degron
strains, RCK1 (Table 1), encodes a protein that is involved in
repression of meiosis. It has been shown that deletion of RCK1
leads to an increased rate of meiosis and sporulation in diploid cells
[32]. Since this gene is downregulated in both the med5/med15 and
the med15/med16 Degron strains it could provide a common
explanation for the up regulation of meiosis and sporulation genes
in the double Degron strains.
Importance of the tail module for transcriptional
activation of target genes for the ACE2 transcription
factor
DSE1 and SCW11, which are specifically down regulated in the
med5/med15 double Degron strain (Table 1), have both been
identified as two of a total of 22 targets genes for the
transcriptional activator Ace2 [33,34]. In order to study the
potential involvement of Ace2 in the synthetic lethality, we
examined our microarray data in more detail. Remarkably, we
found that 11 of the 22 previously identified Ace2 target genes
were significantly down regulated in both the med5/med15 and
med15/med16 double Degron mutants when compared only to the
wild-type strain (Table 2). Several of these genes (i.e. CLN3,
CTS1, AMN1, EGT2, DSE1, SCW11) have been shown to be
induced in G1 and are required for normal progression through
G1 [35–40]. The reason why these genes were not initially scored
as uniquely regulated in the double Degron strains is that several
genes that were significantly down regulated in the double Degron
strains were down regulated to some extent already in the med15
single Degron strain. Down-regulation of three of the Ace2-target
genes was verified using qPCR (Figure 4). One obvious
explanation for this finding is that Ace2 is itself affected by loss
of Med15. However, we found no effects of changes in Ace2
expression in any of our Degron strains and we thus conclude that
the observed effects are most likely caused by a requirement of
Med15 for the ability of Ace2 to affect its target promoters, rather
than a requirement of Med15 for expression of ACE2. Irrespective
of mechanism, our results indicate that the Med15 subunit is
required for activation of genes in the Ace2 pathway.
Depletion of Med15, Med5/Med15 or Med15/Med16
causes cell cycle defects
Several of the genes that we identified as down regulated in the
med15 single Degron strain and the med5/med15 and med15/med16
double Degron strains, encode proteins that function in cell wall
organization, cell wall biogenesis and cell division (Tables 1 and
S1). Notably, the Ace2 transcription factor described above is well
known for its involvement in cell cycle regulation [41]. We
therefore used flow cytometry analyses to study if these strains
showed any cell cycle defects. At 3 hours after switching from the
permissive conditions to the restrictive conditions, we found that
all three strains expressing the MED15 Degron construct behaved
differently from the strains that do not contain theMED15 Degron
(Figure 5). More specifically, in the three strains that contain the
MED15 Degron the fraction of cells in the S/G2 phases was only
22–24%, compared to more than 50% in the strains with normal
Med15 expression. This indicates that loss of Med15 leads to a
delay in cell cycle progression by arresting in G1 phase [42].
Interestingly, this correlates well with a previous report demon-
Figure 4. Confirmation of Ace2 target genes. mRNA levels of the
genes CTS1, EXG1 and YHB1 from WT and Degron-strains were
measured using qPCR and normalized against the WT level. qPCR
levels are compared to the levels determined in the corresponding
microarray assays. The experiments were performed in biological
triplicates, and error bars represent the standard deviation. P-values
where calculated using Student’s t-test. * Indicates p-value , 0.05, **
indicates p-value ,0.01.
doi:10.1371/journal.pone.0073137.g004
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strating that Ace2 activates transcription of G1 specific genes [34].
These results suggest that the requirement of Med15 for Ace2-
mediated transcriptional activation may be reflected by the
observed cell cycle defects in the strains expressing Degron-tagged
Med15.
Discussion
In contrast to the well described structure of Mediator, and the
knowledge we have gained from vast number of reports on the
consequences of deletion of genes that encode Mediator subunits,
very little is known about the molecular mechanisms for Mediator
function in transcriptional regulation. Some favor a recruitment
model, where transcriptional activators are bound to specific
promoter sequences in response to environmental cues transmitted
via different signal transduction pathways. The promoter-bound
transcriptional activators are then suggested to operate by
recruiting Mediator and subsequently the general transcription
machinery including Pol II to the promoter which then becomes
activated (see [43] for a review). Other reports support a model
where promoter-bound transcriptional regulators induce confor-
mational changes in Mediator that are in turn propagated to the
general transcription machinery [44,45]. In addition, there are
several reports of post-translational modifications of both tran-
scriptional activators (i.e. Gal4 [46,47], Mediator subunits (i.e.
Med2 [24,25], and general transcription factors (i.e. TFIIF [48]). It
seems likely that recruitment, induced conformational changes
and post-translational modifications of Mediator and general
transcription factors are sufficient to explain the basic principles
for transcriptional regulation and the ability to integrate signals
from different combinations of activators and repressors that are
bound concomitantly to one promoter, but fine-tuning of gene
expression might also rely on other mechanisms.
We and others have shown that some genes that encode
Mediator tail subunits, i.e. MED5 and MED15 or MED15 and
MED16 are synthetically lethal [26,27]. However, it is difficult to
reveal the primary cause of this lethality using regular double
deletion mutants since these cells are inviable. Previous experi-
ments on single deletion mutants of these subunits have shown that
they display specific non-lethal phenotypes. MED16 deletion
mutants are viable but show some growth defects when grown
under normal conditions including an abnormal elongated shape,
flocculation, heat sensitivity and failure to enter stationary phase
upon nutrient deprivation[49].MED15 single deletion mutants are
also viable in normal growth conditions. However, several reports
have shown that med15 cells are affected under a number of
specific growth conditions i.e. fatty acid media [50], decreased
osmotic stress resistance, and growth defect at high salt concen-
trations [51], decreased resistance to oxidative stress [52]. It is also
reported that sporulation efficiency is decreased in med15 [53].
However, most of these studies are large-scale surveys and not
specifically aimed at Med15. Finally, single med5 mutants are
viable under normal growth conditions but show increased
respiration (grows better than wild type on the nonfermentable
carbon source glycerol), display an increased oxygen consumption
and influences expression of nuclear and mitochondrial OXPHOS
genes [27].
In order to gain a broader understanding of the causes for the
synthetic lethality of MED5/MED15 and MED15/MED16, we
adopted and developed the N-Degron system in order to make it
possible to study the immediate effect on gene expression shortly
after inactivation of two essential genes. We found that double
Degron strains of MED5/MED15 or MED15/MED16 both
showed upregulation of a set of genes involved in meiosis and
sporulation. This could be a result of the down regulation of RCK1,
which we observed in the double Degron strains. Deletion of RCK1
was previously shown to increase the rate of sporulation and it is
therefore believed to be a repressor of meiosis [32]. On the other
hand, the up regulation of meosis and sporulation genes in the
double Degron strains might be the result of derepression, directly
caused by the conditional deletion of MED5/MED15 or MED15/
MED16. We hypothesize that a number of genes that normally
Figure 5. Flow cytometry analyses of Degron constructs. DNA content of cells carrying the indicated Degron constructs was analyzed by flow
cytometry at 3 hours after switching from the permissive to the restrictive growth conditions. Numbers below each histogram indicate the
percentage of cells in the G1-, the S-, and the G2+M-phases, respectively.
doi:10.1371/journal.pone.0073137.g005
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need to be repressed in haploid cells are derepressed in the double
Degron strains and a situation of ‘ectopic meiosis ‘occurs. This
event might lend an explanation for the observed synthetic
lethality.
Expression profiling of the Degron strains also revealed that
several target genes of the Ace2 transcriptional activator were
immediately downregulated in response toMED15 inactivation. In
the budding yeast Saccharomyces cerevisiae, Ace2 controls expression
of factors that are required for septum destruction after cytokinesis
and it has been shown that mutant Ace2 protein causes a G1
phase delay [54]. It is therefore interesting that we found that all
Degron strains that express Med15 as a Degron construct (med15,
med5/med15, and med15/med16) show a G1 delay at the restrictive
conditions (Figure 5). Similar results have also been reported for
an ace2 mutant in fission yeast [55]. Since we could not detect
significant changes in expression of Ace2 itself in any of these
strains, we conclude that the observed effects are caused by the
absence of Med15. We postulate that Med15 transmits regulatory
signals from Ace2 to the Pol II transcription machinery.
Interestingly, much of the transcriptional de-regulation ob-
served in the double Degron strains was also apparent in the med15
single Degron strain. This was also supported by our finding that
inactivation of MED15 using the Degron system causes a clear
temperature senstive phenotype on plates, and lethality when the
cells are grown in liquid cultures. In summary, our study has
identified transcriptional targets of the Mediator Tail module,
thereby providing new insight into the mechanisms underlying
Mediator function.
Supporting Information
Table S1 Comparisons of expression levels between
wild type cells, single Degron mutants and double
Degron mutants.
(XLS)
Table S2 Genes up or downregulated in the Med5/
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